HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received 510 ...
Did you analyze how Bio-Rad Laboratories (BIO) fared in its international operations for the quarter ending December 2024? Given the widespread global presence of this maker of instruments used in ...
Have you assessed how the international operations of Bio-Rad Laboratories (BIO) performed in the quarter ended December 2025? For this maker of instruments used in biomedical research, possessing an ...
Have you evaluated the performance of Bio-Rad Laboratories' (BIO) international operations during the quarter that concluded in September 2024? Considering the extensive worldwide presence of this ...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received ...
* Bio-Rad introduces enhanced options with its IH-COM data management software for managing patient results with the IH-1000 system Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results